Plus, youll receive a free goody bag filled with items to support your progress and a one-month supply of medication
Jennifer Mazurs Post Im excited to kick off the new year by joining the Womens Health Summit at #CES to explore how innovative obesity and cardiometabolic treatments are reshaping consumer health, expectations, and engagement
the medulla, or inner part of the gland, produces epinephrine (adrenaline) and norepinephrine (noradrenaline)
Like any treatment, it carries some risks and potential side effects
These results, combined with orforgliprons once-daily oral dosing and broad scalability, reinforce its potential as a foundational treatment for type 2 diabetes. Eli Lilly also recently presented detailed results from the ATTAIN-1 trial, which investigated orforglipron in adults with obesity or overweight without diabetes, at the European Association for the Study of Diabetes (EASD) Annual Meeting 2025